{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:08:08Z","timestamp":1781910488676,"version":"3.54.5"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Data regarding ocular tuberculosis (OTB) in the United States have not been previously reported. We evaluated trends of OTB compared with other extrapulmonary TB (EPTB).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We estimated the proportion of all EPTB cases (with or without concurrent pulmonary involvement) with OTB reported to the National Tuberculosis Surveillance System during 1993\u20132019. We compared demographics and clinical characteristics of people with OTB and other EPTB during 2010\u20132019. P values were calculated by chi-square test for categorical variables and Kruskal-Wallis for continuous variables.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>During 1993\u20132019, 1766 OTB cases were reported, representing 1.6% of 109 834 all EPTB cases: 200 (0.5% of 37 167) during 1993\u20131999, 395 (1.0% of 41 715) during 2000\u20132009, and 1171 (3.8% of 30 952) during 2010\u20132019. In contrast to persons with other EPTB, persons with OTB were older (median, 48 vs 44 years; P &amp;lt; .01), more likely to be US-born (35% vs 28%; P &amp;lt; .01), more likely to have diabetes (17% vs 13%; P &amp;lt; .01), and less likely to have HIV (1% vs 8%; P &amp;lt; .01). OTB was less likely to be laboratory confirmed (5% vs 75%; P &amp;lt; .01), but patients were more likely to be tested by interferon gamma release assay (IGRA; 84% vs 56%; P &amp;lt; .01) and to be IGRA positive (96% vs 80%; P &amp;lt; .01).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Reported OTB increased during 1993\u20132019 despite decreasing TB, including EPTB; the largest increase occurred during 2010\u20132019. OTB was rarely laboratory confirmed and was primarily diagnosed in conjunction with IGRA results. More research is needed to understand the epidemiology of OTB to inform clinical and diagnostic practices.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofae476","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T23:13:36Z","timestamp":1724368416000},"source":"Crossref","is-referenced-by-count":8,"title":["Epidemiology and Clinical Characteristics of Ocular Tuberculosis in the United States, 1993\u20132019"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1077-9164","authenticated-orcid":false,"given":"Thomas D","family":"Filardo","sequence":"first","affiliation":[{"name":"Division of Tuberculosis Elimination, Centers for Disease Control and Prevention , Atlanta, Georgia ,","place":["USA"]},{"name":"Epidemic Intelligence Service, CDC , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryn","family":"Andrzejewski","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Rochester School of Medicine and Dentistry , Rochester, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Croix","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Rochester School of Medicine and Dentistry , Rochester, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie L","family":"Self","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, Centers for Disease Control and Prevention , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry S","family":"Fraimow","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Cooper Medical School of Rowan University , Camden, New Jersey ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal S","family":"Munsiff","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Rochester School of Medicine and Dentistry , Rochester, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"2024092714534887300_ofae476-B1","author":"Centers for Disease Control and Prevention"},{"key":"2024092714534887300_ofae476-B2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/09273948.2016.1178304","article-title":"Diagnosis of ocular tuberculosis","volume":"26","author":"Ang","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"2024092714534887300_ofae476-B3","author":"Ariail"},{"key":"2024092714534887300_ofae476-B4","doi-asserted-by":"crossref","first-page":"e0237995","DOI":"10.1371\/journal.pone.0237995","article-title":"Incidence, prevalence, and risk factors of infectious uveitis and scleritis in the United States: a claims-based analysis","volume":"15","author":"Zhang","year":"2020","journal-title":"PLoS One"},{"key":"2024092714534887300_ofae476-B5","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.survophthal.2021.10.001","article-title":"Global prevalence and clinical outcomes of tubercular uveitis: a systematic review and meta-analysis","volume":"67","author":"Alli","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"2024092714534887300_ofae476-B6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ophtha.2020.01.008","article-title":"Collaborative ocular tuberculosis study consensus guidelines on the management of tubercular uveitis-report 1: guidelines for initiating antitubercular therapy in tubercular choroiditis","volume":"128","author":"Agrawal","year":"2021","journal-title":"Ophthalmology"},{"key":"2024092714534887300_ofae476-B7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ophtha.2020.06.052","article-title":"Collaborative ocular tuberculosis study consensus guidelines on the management of tubercular uveitis-report 2: guidelines for initiating antitubercular therapy in anterior uveitis, intermediate uveitis, panuveitis, and retinal vasculitis","volume":"128","author":"Agrawal","year":"2021","journal-title":"Ophthalmology"},{"key":"2024092714534887300_ofae476-B8","doi-asserted-by":"crossref","first-page":"e001225","DOI":"10.1136\/bmjresp-2022-001225","article-title":"BTS clinical statement for the diagnosis and management of ocular tuberculosis","volume":"9","author":"Kon","year":"2022","journal-title":"BMJ Open Respir Res"},{"key":"2024092714534887300_ofae476-B9","author":"Smith"},{"key":"2024092714534887300_ofae476-B10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.15585\/mmwr.mm7112a1","article-title":"Tuberculosis\u2014United States, 2021","volume":"71","author":"Filardo","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024092714534887300_ofae476-B11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/ijd.15249","article-title":"Cutaneous tuberculosis of the pinna","volume":"60","author":"Ramesh","year":"2021","journal-title":"Int J Dermatol"},{"key":"2024092714534887300_ofae476-B12","author":"US Census Bureau"},{"key":"2024092714534887300_ofae476-B13","author":"Centers for Disease Control and Prevention"},{"key":"2024092714534887300_ofae476-B14","author":"Michigan Department of Health and Human Services"},{"key":"2024092714534887300_ofae476-B15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00055735-200012000-00010","article-title":"Ocular tuberculosis","volume":"11","author":"Bodaghi","year":"2000","journal-title":"Curr Opin Ophthalmol"},{"key":"2024092714534887300_ofae476-B16","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ajo.2009.11.020","article-title":"Ocular signs predictive of tubercular uveitis","volume":"149","author":"Gupta","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"2024092714534887300_ofae476-B17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/09273948.2014.986584","article-title":"The role of anti-tubercular therapy in patients with presumed ocular tuberculosis","volume":"23","author":"Agrawal","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"2024092714534887300_ofae476-B18","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jamaophthalmol.2017.4485","article-title":"Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)-1","volume":"135","author":"Agrawal","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"2024092714534887300_ofae476-B19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.survophthal.2007.08.015","article-title":"Intraocular tuberculosis\u2014an update","volume":"52","author":"Gupta","year":"2007","journal-title":"Surv Ophthalmol"},{"key":"2024092714534887300_ofae476-B20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1869-5760-3-25","article-title":"Novel multi-targeted polymerase chain reaction for diagnosis of presumed tubercular uveitis","volume":"3","author":"Sharma","year":"2013","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"2024092714534887300_ofae476-B21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/09273948.2014.1004016","article-title":"Tuberculous uveitis","volume":"23","author":"Cunningham ET","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"2024092714534887300_ofae476-B22","doi-asserted-by":"crossref","first-page":"100148","DOI":"10.1016\/j.focus.2023.100148","article-title":"Using electronic health record data to measure the latent tuberculosis infection care cascade in safety-net primary care clinics","volume":"2","author":"Vonnahme","year":"2023","journal-title":"AJPM Focus"},{"key":"2024092714534887300_ofae476-B23","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1097\/INF.0000000000003685","article-title":"Increasing use of interferon gamma release assays among children \u22652 years of age in a setting with low tuberculosis prevalence","volume":"41","author":"Campbell","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"2024092714534887300_ofae476-B24","doi-asserted-by":"crossref","first-page":"e0242055","DOI":"10.1371\/journal.pone.0242055","article-title":"Geographic analysis of latent tuberculosis screening: a health system approach","volume":"15","author":"Bonnewell","year":"2020","journal-title":"PLoS One"},{"key":"2024092714534887300_ofae476-B25","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1177\/0033354919862688","article-title":"Estimates of testing for latent tuberculosis infection and cost, United States, 2013","volume":"134","author":"Marks","year":"2019","journal-title":"Public Health Rep"},{"key":"2024092714534887300_ofae476-B26","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.autrev.2017.10.010","article-title":"Uveitis: diagnostic work-up. A literature review and recommendations from an expert committee","volume":"16","author":"S\u00e8ve","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2024092714534887300_ofae476-B27","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/0002-9394(67)92860-7","article-title":"Ophthalmologic experience in a tuberculosis sanatorium","volume":"64","author":"Donahue","year":"1967","journal-title":"Am J Ophthalmol"},{"key":"2024092714534887300_ofae476-B28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0161-6420(02)00973-9","article-title":"Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in Japan","volume":"109","author":"Morimura","year":"2002","journal-title":"Ophthalmology"},{"key":"2024092714534887300_ofae476-B29","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1001\/jamaophthalmol.2013.71","article-title":"Mycobacterial ocular inflammation: delay in diagnosis and other factors impacting morbidity","volume":"131","author":"Patel","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"2024092714534887300_ofae476-B30","doi-asserted-by":"crossref","first-page":"102018","DOI":"10.1016\/j.tube.2020.102018","article-title":"Insights into the molecular pathogenesis of ocular tuberculosis","volume":"126","author":"Agrawal","year":"2021","journal-title":"Tuberculosis (Edinb)"},{"issue":"Suppl 2","key":"2024092714534887300_ofae476-B31","doi-asserted-by":"crossref","first-page":"S489","DOI":"10.1093\/ofid\/ofz360.1215","article-title":"How do infectious diseases clinicians manage patients with suspected ocular tuberculosis? Results of an Emerging Infections Network survey","volume":"6","author":"Fraimow","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2024092714534887300_ofae476-B32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/09273948.2014.926936","article-title":"Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists","volume":"23","author":"Lou","year":"2015","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofae476\/58893777\/ofae476.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/9\/ofae476\/59361506\/ofae476.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/9\/ofae476\/59361506\/ofae476.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T14:54:04Z","timestamp":1727448844000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofae476\/7739087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,8,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofae476","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,8,22]]},"article-number":"ofae476"}}